Viewing Study NCT06073132


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-26 @ 2:17 AM
Study NCT ID: NCT06073132
Status: RECRUITING
Last Update Posted: 2025-11-19
First Post: 2023-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Sponsor: TWi Biotechnology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module